Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash Flows from Operating Activities
Net loss	$ (1,047)	$ (312)	$ (1,623)	$ (694)	$ 1,812
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization expense			120	120
Amortization of debt discount	115	10	154	30
Fair value of common shares issued in connection with the conversion of accounts payable			537
Fair value of restricted stock units			5
Fair value of warrants issued in connection with convertible notes payable			29
Changes in operating assets and liabilities:
Vendor advances			(1,515)
Prepaid expenses and other current assets			(2)	(17)
Accounts payable and accrued expenses			143	576
Net cash provided by (used in) operating activities			(2,152)	15
Cash Flows from Financing Activities
Proceeds from common stock issued for cash in connection with the closing of the initial public offering			5,524
Proceeds, net of offering costs from notes payable - officers			142
Payment of deferred offering costs			(390)	(353)
Net cash provided by (used in) financing activities			5,276	(353)
Net increase (decrease) in cash			3,124	(338)
Cash beginning of period			93	437	437
Cash end of period	$ 3,217	$ 99	3,217	99	$ 93
Supplemental cash flows disclosures:
Interest paid
Taxes paid
Supplemental non-cash financing disclosures:
Reclassification of deferred offering costs to shareholders’ equity			872
Conversion of convertible notes payable and accrued interest to shareholders’ equity			884
Conversion of accounts payable to shareholders’ equity			1,014
Conversion of amounts due to related parties to shareholders’ equity			$ 4